Our Process
Using gene expression data from patient samples, we apply our proprietary algorithm to classify patients by their unique molecular signatures. This process assigns each patient to a specific molecular subtype. From this stratification, we can identify likely responders for Clinical Trial Enrollment, as well as retroactively evaluate treatment response in each patient subtype.
Heterogenous Systemic Autoimmune Disorders
![Sad Infographic Sad Infographic](https://immutype.com/wp-content/uploads/sad-infographic-1.png)
Get in Touch
If you are interested in ImmuType services and would like additional information.
Engage ImmuType